Peter Lindgren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Lindgren has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ajlana Mulic-Lutvica
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
2 shared publications - Anna-Karin Wikström
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
2 shared publications - Johan Wikström
Department of Surgical Sciences, Neuroradiology, Uppsala University, Uppsala, Sweden
2 shared publications O Axelsson
Department of Women’s and Children’s Health/Obstetrics and Gynaecology, Uppsala University, Uppsala, Sweden
2 shared publicationsO. Axelsson
Department of Women's and Children's Health; Uppsala University; Uppsala Sweden
2 shared publications- Sara Sohlberg
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
2 shared publications
Latest Publications
- Open Access
- 13 September 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-10
‘It made you think twice’ – an interview study of women’s perception of a web-based decision aid concerning screening and diagnostic testing for fetal anomalies
Enabling women to make informed decisions is a key objective in the guidelines governing prenatal screening and diagnostics. Despite efforts to provide information, research shows that women’s choice of prenatal screening is often not based on informed decisions. The aim of this study was to investigate pregnant women’s perceptions of the use of an interactive web-based DA, developed to initiate a process of reflection and deliberate decision-making concerning screening and testing for fetal anomalies. A qualitative study was applied and individual interviews were conducted. Seventeen pregnant women attending antenatal healthcare in Uppsala County, Sweden, who had access to the decision aid were interviewed. Eleven opted to use the decision aid and six did not. Data were analysed by systematic text condensation. Women appreciated the decision aid, as it was easily accessible; moreover, they emphasised the importance of a reliable source. It helped them to clarify their own standpoints and engaged their partner in the decision-making process. Women described the decision aid as enhancing their awareness that participating in prenatal screening and diagnostics was a conscious choice. Those who chose not to use the web-based decision aid when offered reported that they already had sufficient knowledge. The decision aid was able to initiate a process of deliberate decision-making in pregnant women as a result of their interaction with the tool. Access to a web-based decision aid tool can be valuable to expectant parents in making quality decisions regarding screening for fetal anomalies.
- 13 September 2016
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 16 (1) , 1-10
Open Access‘It made you think twice’ – an interview study of women’s perception of a web-based decision aid concerning screening and diagnostic testing for fetal anomalies
Enabling women to make informed decisions is a key objective in the guidelines governing prenatal screening and diagnostics. Despite efforts to provide information, research shows that women’s choice of prenatal screening is often not based on informed decisions. The aim of this study was to investigate pregnant women’s perceptions of the use of an interactive web-based DA, developed to initiate a process of reflection and deliberate decision-making concerning screening and testing for fetal anomalies. A qualitative study was applied and individual interviews were conducted. Seventeen pregnant women attending antenatal healthcare in Uppsala County, Sweden, who had access to the decision aid were interviewed. Eleven opted to use the decision aid and six did not. Data were analysed by systematic text condensation. Women appreciated the decision aid, as it was easily accessible; moreover, they emphasised the importance of a reliable source. It helped them to clarify their own standpoints and engaged their partner in the decision-making process. Women described the decision aid as enhancing their awareness that participating in prenatal screening and diagnostics was a conscious choice. Those who chose not to use the web-based decision aid when offered reported that they already had sufficient knowledge. The decision aid was able to initiate a process of deliberate decision-making in pregnant women as a result of their interaction with the tool. Access to a web-based decision aid tool can be valuable to expectant parents in making quality decisions regarding screening for fetal anomalies.
- Open Access
- 8 September 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 44 (S1) , 181
P01.03: Women and partners coming for a first trimester combined (CUB) test; why they choose it, how are they informed, knowledge about Down's syndrome and their plans if Down's syndrome is diagnosed
- 8 September 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 44 (S1) , 181
Open AccessP01.03: Women and partners coming for a first trimester combined (CUB) test; why they choose it, how are they informed, knowledge about Down's syndrome and their plans if Down's syndrome is diagnosed
- 17 August 2010
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (11) , 1422-1425
Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre‐eclampsia
The aim was to estimate the risk of maternal hypertensive complications following first- or second-trimester invasive diagnostic procedures, i.e. chorionic villus sampling (CVS) and amniocentesis (AC). Odds ratios (ORs) for gestational hypertension, mild pre-eclampsia or severe pre-eclampsia were calculated for women who underwent CVS (n = 1 984) or AC (n = 21 748) compared with non-exposed women (n = 47 854). No increase in the development of gestational hypertension, mild pre-eclampsia or severe pre-eclampsia was observed. The results do not support an association between invasive procedures for fetal karyotyping and subsequent gestational hypertension or pre-eclampsia.
- 17 August 2010
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 117 (11) , 1422-1425
Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre‐eclampsia
The aim was to estimate the risk of maternal hypertensive complications following first- or second-trimester invasive diagnostic procedures, i.e. chorionic villus sampling (CVS) and amniocentesis (AC). Odds ratios (ORs) for gestational hypertension, mild pre-eclampsia or severe pre-eclampsia were calculated for women who underwent CVS (n = 1 984) or AC (n = 21 748) compared with non-exposed women (n = 47 854). No increase in the development of gestational hypertension, mild pre-eclampsia or severe pre-eclampsia was observed. The results do not support an association between invasive procedures for fetal karyotyping and subsequent gestational hypertension or pre-eclampsia.
- Open Access
- 11 August 2008
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 32 (3) , 387
OP22.08: Invasive procedures for fetal karyotyping; No cause of a subsequent gestational hypertension/preeclampsia
- 11 August 2008
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 32 (3) , 387
Open AccessOP22.08: Invasive procedures for fetal karyotyping; No cause of a subsequent gestational hypertension/preeclampsia
- 30 November 1988
- Vol. 85 (48) , 4217-9
[Current views on prenatal diagnosis and fetal medicine].